The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Therapeutic Effect of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis
Authors
Keywords
-
Journal
Evidence-based Complementary and Alternative Medicine
Volume 2016, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2016-07-04
DOI
10.1155/2016/3593951
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD
- (2016) Helen L. Reeves et al. DIGESTIVE DISEASES AND SCIENCES
- Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway
- (2016) Shengnan Wei et al. PLoS One
- Berberine Ameliorates Hepatic Steatosis and Suppresses Liver and Adipose Tissue Inflammation in Mice with Diet-induced Obesity
- (2016) Ting Guo et al. Scientific Reports
- Effect of Berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters
- (2015) Xiao-Yang Li et al. Journal of Translational Medicine
- Nonalcoholic fatty liver disease and statins
- (2015) Konstantinos Tziomalos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Efficacy of Berberine in Patients with Non-Alcoholic Fatty Liver Disease
- (2015) Hong-Mei Yan et al. PLoS One
- Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells
- (2013) Yan Zhou et al. FITOTERAPIA
- Effect of Berberine Administration on Metabolic Syndrome, Insulin Sensitivity, and Insulin Secretion
- (2013) Karina G. Pérez-Rubio et al. Metabolic Syndrome and Related Disorders
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Extensive Intestinal First-Pass Elimination and Predominant Hepatic Distribution of Berberine Explain Its Low Plasma Levels in Rats
- (2010) Y.-T. Liu et al. DRUG METABOLISM AND DISPOSITION
- Berberine: a potential phytochemical with multispectrum therapeutic activities
- (2010) Parameswara Rao Vuddanda et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
- (2010) Christopher D. Williams et al. GASTROENTEROLOGY
- Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats
- (2009) Yitong Liu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Epidemiology of non-alcoholic fatty liver disease in China
- (2008) Jian-Gao Fan et al. JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started